CD2H COVID-19

Cardiovascular Risk Stratification in Covid-19

Purpose

This retrospective double-cohort study seeks to: 1. Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and 2. Develop a method of cardiovascular risk stratification in COVID-19

Conditions

Covid19
Cardiovascular Risk Factor

Eligibility

Eligible Ages: Between 18 Years and 89 Years
Eligible Sex: All
Accepts Healthy Volunteers: No

Inclusion Criteria

age >=18y - available data on Covid19 test in the electronic medical record (either positive or negative)

Exclusion Criteria

no data of Covid19 test

Study Design

Phase
Study Type: Observational
Observational Model: Cohort
Time Perspective: Retrospective

Arm Groups

Arm	Description	Assigned Intervention
Covid19-positive	Covid19 test positive. age >= 18 y.
Covid19-negative	Covid19 test negative. age >=18y

Recruiting Locations

More Details

NCT ID: NCT04555187
Status: Completed
Sponsor: Oregon Health and Science University

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.